The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer

<p>Muscle invasive bladder cancer (MIBC) has a poor prognosis. Currently, therapy consists of radical radiotherapy or cystectomy with or without chemotherapy. The average age of patients with MIBC is high and older patients are less able to tolerate surgery or chemoradiation due to their impai...

詳細記述

書誌詳細
第一著者: Groselj, B
その他の著者: Kiltie, A
フォーマット: 学位論文
言語:English
出版事項: 2014
主題:

類似資料